We are live on ! Find out more
FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.89B
1-Year Est. Return 201.1%
This Fund
S&P 500
This Quarter Est. Return
-4.89%
1 Year Est. Return
+201.1%
3 Year Est. Return
+879.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$114M
Cap. Flow
-$31M
Cap. Flow %
-2.92%
Top 10 Hldgs %
68.2%
Holding
44
New
2
Increased
8
Reduced
8
Closed
3

Top Buys

1
HLVX
HilleVax
HLVX
+$110M
2
KRYS icon
Krystal Biotech
KRYS
+$14.3M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$13.9M
4
TARS icon
Tarsus Pharmaceuticals
TARS
+$5.56M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$4.16M

Top Sells

1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$77.2M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$28.3M
3
BCYC
Bicycle Therapeutics
BCYC
+$26.5M
4
PCVX icon
Vaxcyte
PCVX
+$12.1M
5
ALPN
Alpine Immune Sciences Inc
ALPN
+$10.3M

Sector Composition

1 Healthcare 98.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARQT icon
1
Arcutis Biotherapeutics
ARQT
$3.47B
$180M 16.96%
8,434,232
– –
HLVX
2
DELISTED
HilleVax
HLVX
$101M 9.58%
+9,285,682
New +$110M
KRYS icon
3
Krystal Biotech
KRYS
$10.1B
$71.9M 6.79%
1,095,407
+229,157
+26% +$14.3M
MIRM icon
4
Mirum Pharmaceuticals
MIRM
$7.16B
$69.4M 6.55%
3,566,912
– –
KDNY
5
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$62.9M 5.93%
3,595,026
+882,985
+33% +$13.9M
SNDX icon
6
Syndax Pharmaceuticals
SNDX
$2.01B
$61.5M 5.8%
3,195,403
– –
PHAT icon
7
Phathom Pharmaceuticals
PHAT
$875M
$49.2M 4.64%
5,827,415
– –
SRRA
8
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$47.9M 4.52%
870,636
-1,471,562
-63% -$77.2M
IMGO
9
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$39.8M 3.75%
2,971,274
– –
PCVX icon
10
Vaxcyte
PCVX
$8.09B
$38.9M 3.67%
1,787,405
-522,149
-23% -$12.1M
CRNX icon
11
Crinetics Pharmaceuticals
CRNX
$8.88B
$26.4M 2.49%
1,414,823
– –
TARS icon
12
Tarsus Pharmaceuticals
TARS
$2.52B
$26.1M 2.46%
1,787,527
+370,370
+26% +$5.56M
ALPN
13
DELISTED
Alpine Immune Sciences Inc
ALPN
$25.4M 2.4%
2,985,757
-1,200,000
-29% -$10.3M
TCDA
14
DELISTED
Tricida, Inc. Common Stock
TCDA
$20.2M 1.9%
2,082,093
– –
COGT icon
15
Cogent Biosciences
COGT
$6.48B
$18.9M 1.78%
2,094,154
-557,600
-21% -$3.81M
ANAB icon
16
AnaptysBio
ANAB
$1.6B
$18.3M 1.72%
899,700
– –
GRCL
17
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$17.1M 1.62%
3,111,551
-334,422
-10% -$1.04M
KALV
18
DELISTED
KalVista Pharmaceuticals
KALV
$15.5M 1.46%
1,572,192
– –
MRUS
19
DELISTED
Merus
MRUS
$15.3M 1.44%
673,979
+45,000
+7% +$939K
FLACU
20
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$14.8M 1.4%
1,501,000
– –
REPL icon
21
Replimune Group
REPL
$799M
$14.1M 1.33%
806,267
+89,505
+12% +$1.47M
GRTS
22
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$12.7M 1.2%
5,237,348
– –
ARVN icon
23
Arvinas
ARVN
$518M
$12M 1.13%
285,331
+15,000
+6% +$753K
PASG icon
24
Passage Bio
PASG
$15.8M
$11.8M 1.12%
250,461
– –
VRDN icon
25
Viridian Therapeutics
VRDN
$1.99B
$11.3M 1.07%
980,302
-759,228
-44% -$10.2M
1
2

Similar funds

GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
DACG
Donor Advised Charitable Giving San Francisco, California $3.92B AUM 59.92% 1-Year Est. Return